NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
10 Posts Not to Miss from EHA 2025
Jun 15, 2025, 11:17

10 Posts Not to Miss from EHA 2025

The European Hematology Association (EHA) Congress 2025 is officially underway in Milan. From June 12 to 15, hematology professionals from around the world are gathering to share the latest research, clinical advances, and innovations shaping the future of hematologic care.

EHA 2025 features a comprehensive scientific program that includes high-level plenary sessions, oral abstract presentations, clinical and translational research highlights, and disease-specific updates across malignant and non-malignant hematologic conditions. With hundreds of abstracts presented, as well as interactive education sessions and collaborative forums, the congress offers unparalleled insight into evolving standards of care, novel therapies, and mechanisms of disease.

This year’s meeting also celebrates the 30th edition of the EHA Congress, a milestone reflecting three decades of scientific excellence, global collaboration, and commitment to improving outcomes for patients with blood disorders. The program places a strong emphasis on innovation, equity, and mentorship, highlighted by prestigious award recognitions honoring leaders in the field.

Our team at OncoDaily has handpicked 10 highlights from the firts day of EHA 2025. Scroll down to catch the highlights, dive into the science, and hear directly from the people shaping the future of cancer care.

Bruno Paiva:
“EHA2025  had Carmen González Díaz-Cano presenting the phenotype and genetic landscape of clonotypic cells in myeloma and amyloidosis mmsm. These cells may be immature, carry some mutations but not drivers of progression. May explain some discordances between NGF/NGS MRD results.”
EHA2025-hemostasistoday
“EHA 2025 lifetime achievement award to Jesús San Miguel: “Happiness is not doing what you want but wanting what you do” JSM quotes the words of JP Sartre and shares his treasures with the audience: the big families he built at home.”
EHA2025-hemostasistoday
Naveen Pemmaraju:
“Wonderful time spent with Rami Komrokji
 at EHA 2025 in between sessions !”
EHA2025-hemostasistoday
The Lancet Haematology:
“Today at EHA 2025 Dr Paul J Bröckelmann shared insights from The Lancet Haematology Commission on AdverseEvents. Our 2025 Series updates priority areas on measuring & managing toxicities in new haematology treatment.”
EHA2025-hemostasistoday
María José Calasanz :
“EHA 2025 lifetime achievement award to Dr. Jesús San Miguel. Congratulationsssssssss.”
EHA2025-hemostasistoday
Monica Rivera:

“Very productive first meeting with my mentee Thanks European Hematology Association for this mentorship program.”

EHA2025-hemostasistoday
 Julia Maxson:
“If you are at EHA 2025. I hope you can catch Dr. SamanthaTauchmann’s talk on the role of KAT7 in SETBP1-driven epigenetic dysregulation on Sunday! Session: s441 Novel and experimental approaches to study and treat MPN.”
EHA2025-hemostasistoday
“Enticing data presented by Matt Ku from Melbourne for JNJ4496 a bispecific CD19/CD20 CAR T-cell product; rates of ICANS also seem perhaps a bit better than axicel too EHA 2025.”
EHA2025-hemostasistoday
“It has been an honor to have served the European Hematology Association as a Board Member in the term 2021-2025. I hope to have made impact to foster hematology in Europe and beyond Borderless Hematology.”
EHA2025-hemostasistoday
Josep Domingo-Domenech :
“So proud of my sister Eva Domingo-Domenech. The legacy continues ! T-cell lymphomas.”
EHA2025-hemostasistoday

To stay on top of everything happening at EHA 2025, keep following  Hemostasis Today.

Written by Nare Hovhannisyan, MD

Bruno Paiva Eddie Cliff EHA 2025 Hematology hematosistoday Josep Domingo-Domenech Julia Maxson María José Calasanz Monica Rivera Naveen Pemmaraju Raul Cordoba The Lancet Haematology
NewsFeed